Overexpression of 14-3-3


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2020
Historique:
received: 04 04 2020
revised: 22 05 2020
accepted: 27 05 2020
entrez: 21 7 2020
pubmed: 21 7 2020
medline: 29 4 2021
Statut: epublish

Résumé

The protein 14-3-3

Identifiants

pubmed: 32685532
doi: 10.1155/2020/8435420
pmc: PMC7321506
doi:

Substances chimiques

14-3-3 Proteins 0
Biomarkers, Tumor 0
YWHAZ protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8435420

Informations de copyright

Copyright © 2020 Qiao Wu et al.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Oncotarget. 2016 Jul 19;7(29):46750-46767
pubmed: 27102149
Expert Opin Ther Targets. 2010 Dec;14(12):1343-54
pubmed: 21058923
Asian Pac J Cancer Prev. 2012;13(4):1253-9
pubmed: 22799314
Semin Cell Dev Biol. 2011 Sep;22(7):705-12
pubmed: 21983031
Cancer Res. 2007 Aug 15;67(16):7901-6
pubmed: 17699796
Breast Cancer Res Treat. 2017 Oct;165(3):633-643
pubmed: 28643021
Cancer Med. 2016 Jul;5(7):1405-15
pubmed: 27139182
Cell Death Dis. 2018 Feb 7;9(2):159
pubmed: 29415983
J Cell Mol Med. 2020 Jan;24(1):954-964
pubmed: 31709727
Cell. 1997 Dec 26;91(7):961-71
pubmed: 9428519
J Proteome Res. 2006 May;5(5):1143-54
pubmed: 16674103
Oncotarget. 2016 Aug 23;7(34):55191-55210
pubmed: 27409422
Nat Rev Gastroenterol Hepatol. 2016 May;13(5):261-80
pubmed: 27095655
Oncotarget. 2016 Mar 29;7(13):15854-67
pubmed: 26910835
Cancer Med. 2019 Feb;8(2):783-794
pubmed: 30656845
Mol Cancer. 2009 Jul 30;8:53
pubmed: 19642975
Drug Discov Today. 2016 Feb;21(2):278-87
pubmed: 26456530
JAMA Oncol. 2015 Jul;1(4):505-27
pubmed: 26181261
Am J Transl Res. 2009 Jun 08;1(4):326-40
pubmed: 19956445
Nat Cell Biol. 2005 Mar;7(3):278-85
pubmed: 15696159
PLoS One. 2016 Feb 01;11(2):e0147467
pubmed: 26828594
Oncogene. 2001 Oct 1;20(44):6331-8
pubmed: 11607836
J Exp Clin Cancer Res. 2019 Jan 3;38(1):3
pubmed: 30606233
Med Oncol. 2010 Sep;27(3):791-7
pubmed: 19685192
Chin Clin Oncol. 2016 Oct;5(5):65
pubmed: 27829278
Carcinogenesis. 2018 Mar 8;39(3):493-502
pubmed: 29390122
Cell Prolif. 2019 Sep;52(5):e12654
pubmed: 31222857
Cell. 1996 Mar 22;84(6):889-97
pubmed: 8601312
Parasitol Int. 2017 Aug;66(4):426-431
pubmed: 27989833

Auteurs

Qiao Wu (Q)

Department of Hepatobiliary Surgery, Beijing Chao Yang Hospital, Capital Medical University, Beijing 100020, China.

Hua Fan (H)

Department of Hepatobiliary Surgery, Beijing Chao Yang Hospital, Capital Medical University, Beijing 100020, China.

Ren Lang (R)

Department of Hepatobiliary Surgery, Beijing Chao Yang Hospital, Capital Medical University, Beijing 100020, China.

Xianliang Li (X)

Department of Hepatobiliary Surgery, Beijing Chao Yang Hospital, Capital Medical University, Beijing 100020, China.

Xingmao Zhang (X)

Department of Hepatobiliary Surgery, Beijing Chao Yang Hospital, Capital Medical University, Beijing 100020, China.

Shaocheng Lv (S)

Department of Hepatobiliary Surgery, Beijing Chao Yang Hospital, Capital Medical University, Beijing 100020, China.

Qiang He (Q)

Department of Hepatobiliary Surgery, Beijing Chao Yang Hospital, Capital Medical University, Beijing 100020, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH